e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Lung function: exploring the boundaries of the respiratory system
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency
James Stockley (Birmingham, United Kingdom), James Stockley, Laura Smith, Brendan Cooper, Robert Stockley, Elizabeth Sapey
Source:
International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Session:
Lung function: exploring the boundaries of the respiratory system
Session type:
Thematic Poster Session
Number:
960
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
James Stockley (Birmingham, United Kingdom), James Stockley, Laura Smith, Brendan Cooper, Robert Stockley, Elizabeth Sapey. Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency. Eur Respir J 2015; 46: Suppl. 59, 960
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
From pulmonary gas exchange to the interpretation of arterial blood gases
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Lung clearance index in alpha-1-antitrypsin deficiency - A follow up
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Improved characterization of obstructive airways diseases by parameterization of specific resistance loops
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Lung function in never smoking patients with alpha1antitrypsin deficiency
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Multiple breath washout for monitoring alpha-1-antitrypsin deficiency related lung disease
Source: Annual Congress 2013 –New perspectives of lung function assessment in children
Year: 2013
Lung function decline in patients with severe alpha
1
-antitrypsin deficiency
Source: International Congress 2014 – Respiratory function: quality and new technologies
Year: 2014
Evaluation of protease-antiprotease imbalance in moderate COPD without antitrypsin deficiency
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019
Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Genetic influences on lung function decline in AATD
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Decline in lung function in patients with alpha-1-antitrypsin deficiency and airflow obstruction
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Functional and immunological abnormalities in patients with severe asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Change in lung function and CT lung density in alpha1 antitrypsin deficiency patients under augmentation therapy
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Prevalence of small airway dysfunction among GOLD stages in COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002
Common airway variants and chronic obstructive pulmonary disease
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept